obesity-995x60.png
FEATURED ARTICLES
The Cost And ROI Of Agentic AI In Clinical Trials: What Sponsors And CROs Need To Know
Beroe Inc. analyst T.G. Prasanna discusses agentic AI for clinical research and how it must be evaluated as a regulated operating cost transformation, with platform, orchestration, compliance, validation, and oversight costs modeled together.
-
![programming, digital transformation, binary code-GettyImages-1321462048]( "Bridging The Gap Between Protocol And Execution In Clinical Trials")
Bridging The Gap Between Protocol And Execution In Clinical TrialsTransform passive trial operations into active infrastructure. Learn how a digitized execution layer builds in compliance, enables effective AI, and frees teams for critical decision-making.
-
![GettyImages-2166551077-AI-Artificial Intelligence-hands]( "AI's Bottleneck In Clinical Trials Moved, And Most People Missed It")
AI's Bottleneck In Clinical Trials Moved, And Most People Missed ItAI has accelerated drug discovery, but the real bottleneck is now clinical trial operations. Explore why regulatory success depends on auditable data governance, not model speed.
-
![Artificial Intelligence (AI) Digital Concept GettyImages-1160995648]( "From Data Silos to Connected Intelligence: How AI Is Unifying Clinical Research Data")
From Data Silos to Connected Intelligence: How AI Is Unifying Clinical Research DataAI tools like TrialKit AI revolutionize clinical trials by integrating diverse data sources, including wearables, breaking silos, enhancing insights, and enabling smarter, more patient-centered research.
SERVICES AND PRODUCTS
Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.
Cardinal Symptom Monitoring for Parkinson's and Huntington's Disease Trials
Continuous, objective tracking of cardinal symptoms in chronic diseases can support a better understanding of disease progression and treatment response.
Rapidly reduced timelines and waste, and the prevention of costly product shortages
In a world that is constantly changing, the development of innovative personalised medicine is helping more of us to live healthier lives for longer. These leaps forward in drug development create new hope for patients.
Yet operating high-value, time-sensitive supply chains naturally brings additional challenge and risk. Challenge and risk that require a step change in production approach to effectively balance patient-centricity with commercial viability.
Almac Trial Coordinator™ is a unified eClinical orchestration solution designed to simplify the execution of complex clinical trials. It brings together core trial functions including Interactive Response Technology (IRT), electronic Clinical Outcome Assessments (eCOA), eConsent, visit and participant management, and clinical supply oversight within a single, cohesive ecosystem.
Rather than operating as a collection of disconnected point solutions, Almac Trial Coordinator™ is designed to coordinate workflows, data, and users across the clinical trial lifecycle. The result is a more efficient, transparent, and site-friendly way to run global studies.
Boost patient engagement. Simplify and reduce site workload. Enable real-time, local currency payments through the patient’s preferred method.
Trial Enablement Solutions
Digital health technologies have the potential to transform clinical trials, yet without careful planning and operational support, their implementation can create complexity, increase site burden, and jeopardize data quality.
Backed by over 20 years of experience across nearly 300 industry-sponsored trials, Ametris’ Digital Health Operations team delivers end-to-end trial enablement services to ensure seamless technology deployment, reduce site burden, and capture reliable, high-quality data.